
Median US and Europe M&A EV/EBITDA multiples
Source: PitchBook, Q2 2025 Global M&A Report, data as of June 30, 2025. Past performance is not a reliable indicator of future results.
Key takeaway
The European private market has historically executed deal flow at lower EV/EBITDA multiples than the US and its more fragmented corporate landscape is offering fertile ground for private equity stakeholders, particularly co-investors targeting mid-life assets.
In today’s more uncertain macro environment, Europe’s investment landscape is increasingly drawing attention from investors seeking global diversification and outperformance potential. While the more mature US market remains a dominant force, Europe’s ~$1.37 trillion private equity market is projected to grow at a robust 12.2% CAGR through 20291 supported by a more unified EU policy framework and strategic alignment across the region in terms of crucial sectors that can build cross border resilience and growth.
Many attractive private equity deals are taking place across Europe. And co-investment strategies targeting high-quality mid-life private equity assets are showing significant upside potential by catalyzing strategic M&A, infusing crucial capital for operational enhancements, or serving as an external source of valuation ahead of a planned liquidity event. These transactions are harnessing Europe’s tailwinds and creating transformative growth while offering a distinct buying opportunity for investors based on Europe’s lower valuations. Read our recently published, “Harnessing European Tailwinds with Mid-life Co-investments” for a closer look at how these transactions are unlocking value in today’s evolving private equity landscape.
The HarbourVest advantage
- Preqin, The Future of Alternatives 2029, dated September 2024.
Diversification does not ensure a profit or protect against a loss.
HarbourVest Partners, LLC (“HarbourVest”) is a registered investment adviser under the Investment Advisers Act of 1940. This material is solely for informational purposes; the information should not be viewed as a current or past recommendation or an offer to sell or the solicitation to buy securities or adopt any investment strategy. In addition, the information contained in this document (i) may not be relied upon by any current or prospective investor and (ii) has not been prepared for marketing purposes. In all cases, interested parties should conduct their own investigation and analysis of the any information set forth herein and consult with their own advisors. HarbourVest has not acted in any investment advisory, brokerage or similar capacity by virtue of supplying this information. The opinions expressed herein represent the current, good faith views of the author(s) at the time of publication, are not definitive investment advice, and should not be relied upon as such. This material has been developed internally and/or obtained from sources believed to be reliable; however, HarbourVest does not guarantee the accuracy, adequacy or completeness of such information. The information is subject to change without notice and HarbourVest has no obligation to update you. There is no assurance that any events or projections will occur, and outcomes may be significantly different than the opinions shown here. This information, including any projections concerning financial market performance, is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. The information contained herein must be kept strictly confidential and may not be reproduced or redistributed in any format without the express written approval of HarbourVest.
Direct Co-Invest Investing Risks. Direct co-investments result in a GP holding a minority equity interest in portfolio companies where it does not expect to be able to protect its portfolio investments or to control or influence effectively the business or affairs of such entities. In such investments, the GP will rely on the existing management and board of directors of such companies, which could include representatives of other financial investors with whom it is not affiliated and whose interests could at times conflict with it’s interests. Such investments involve additional risks not present in investments where the GP has control, including the possibility that such other investors have financial difficulties resulting in a negative impact on such investments or take actions contrary to it’s investment objectives.

